C. Albano

发表

Comparison of transfers to Fallopian tubes or uterus after ICSI.

P. Devroey, A. De Vos, P. Platteau, 2003, Reproductive biomedicine online.

Endometrial integrin expression in the early luteal phase in natural and stimulated cycles for in vitro fertilization.

P. Devroey, P. Platteau, J. Smitz, 2003, European journal of obstetrics, gynecology, and reproductive biology.

Impact of ovarian stimulation on corpus luteum function and embryonic implantation.

P. Devroey, J. Smitz, A. Tavaniotou, 2002, Journal of reproductive immunology.

Anovulatory infertility.

R. Palermo, L. Giambanco, C. Albano, 1994, Acta Europaea fertilitatis.

Immature oocyte in-vitro maturation: clinical aspects.

P. Devroey, R. Cortvrindt, E. Papanikolaou, 2005, Reproductive biomedicine online.

Abnormal endometrial development occurs during the luteal phase of nonsupplemented donor cycles treated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists.

E. Kolibianakis, P. Devroey, A. V. Van Steirteghem, 2003, Fertility and sterility.

Exogenous luteinizing hormone activity may influence the treatment outcome in in vitro fertilization but not in intracytoplasmic sperm injection cycles.

P. Devroey, P. Platteau, J. Smitz, 2004, Fertility and sterility.

Fertilization and early embryology: Embryo quality and pregnancy potential of fresh compared with frozen embryos—is freezing detrimental to high quality embryos?

G. Garrisi, D. Navot, A. Copperman, 1995 .

Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy.

H. Tournaye, E. Kolibianakis, P. Devroey, 2003, Fertility and sterility.

Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation.

P. Devroey, A. Steirteghem, J. Smitz, 1997, Fertility and sterility.

The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist Cetrorelix.

P. Devroey, J. Smitz, H. Riethmüller-Winzen, 1998, Fertility and sterility.

Rescue IVF and coasting with the use of a GnRH antagonist after ovulation induction.

P. Devroey, P. Platteau, H. Fatemi, 2002, Reproductive biomedicine online.

An open, randomized single-centre study to compare the efficacy and convenience of follitropin beta administered by a pen device with follitropin alpha administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSI.

H. Tournaye, P. Devroey, P. Platteau, 2003, Human reproduction.

Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix.

P. Devroey, K. Diedrich, R. Felberbaum, 2001, Fertility and sterility.

Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study.

M. Grigat, P. Devroey, K. Diedrich, 2000, Human reproduction.

Immature oocyte in-vitro maturation: clinical

P. Devroey, R. Cortvrindt, E. Papanikolaou, 2005 .

Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycles.

H. Tournaye, P. Devroey, A. V. Van Steirteghem, 1999, Human reproduction.

Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles.

F. Ubaldi, P. Devroey, A. V. Van Steirteghem, 1996, Human reproduction.

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group.

P. Devroey, J. Smitz, J. Engel, 2000, Human reproduction.

Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide®) in controlled ovarian stimulation for assisted reproduction

P. Devroey, K. Diedrich, R. Felberbaum, 2000, Archives of Gynecology and Obstetrics.

Improving in vitro maturation of oocytes in the human taking lessons from experiences in animal species.

P. Devroey, R. Cortvrindt, J. Smitz, 2001, Reproduction in domestic animals = Zuchthygiene.

Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up.

E. Kolibianakis, P. Devroey, A. V. Van Steirteghem, 2002, Fertility and sterility.

The impact of LH serum concentration on the clinical outcome of IVF cycles in patients receiving two regimens of clomiphene citrate/gonadotrophin/0.25 mg cetrorelix.

P. Devroey, A. Tavaniotou, A. V. van Steirteghem, 2003, Reproductive biomedicine online.

Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to 'friendly IVF'?

P. Devroey, J. Engel, K. Diedrich, 2002, Human reproduction.

Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix.

P. Devroey, J. Smitz, A. Tavaniotou, 2001, Human reproduction.

Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (Cetrorelix).

P. Devroey, J. Smitz, K. Diedrich, 1996, Human reproduction.

Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist.

P. Devroey, J. Smitz, A. Tavaniotou, 2002, Fertility and sterility.

Endocrinology: Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist Cetrorelix in intracytoplasmic sperm injection cycles

F. Ubaldi, P. Devroey, A. Steirteghem, 1996 .

Pregnancy and birth in an in-vitro fertilization cycle after controlled ovarian stimulation in a woman with a history of allergic reaction to human menopausal gonadotrophin.

P. Devroey, J. Smitz, M. Camus, 1996, Human reproduction.

Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists.

H. Tournaye, E. Kolibianakis, P. Devroey, 2004, Fertility and sterility.

Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles.

H. Tournaye, E. Kolibianakis, P. Devroey, 2003, The Journal of clinical endocrinology and metabolism.

GnRH antagonists in poor responders

E. Kolibianakis, P. Devroey, K. Zikopoulos, 2004, Acta obstetricia et gynecologica Scandinavica.

Human Oocytes Reversibly Arrested in Prophase I by Phosphodiesterase Type 3 Inhibitor In Vitro1

P. Devroey, R. Cortvrindt, T. Adriaenssens, 2003, Biology of reproduction.

Plasma and follicular fluid concentrations of LHRH antagonist cetrorelix (Cetrotide®) in controlled ovarian stimulation for IVF

P. Devroey, J. Smitz, O. Ortmann, 2002, Archives of Gynecology and Obstetrics.

Avoidance of multiple pregnancies after ovulation induction by supernumerary preovulatory follicular reduction.

P. Devroey, R. Cortvrindt, P. Platteau, 2001, Fertility and sterility.

Gonadotropin-releasing hormone antagonist: how good is the new hope?

P. Devroey, P. Platteau, C. Albano, 2001, Current opinion in obstetrics & gynecology.

Quintuplet pregnancy following transfer of two blastocysts: Case report.

P. Devroey, P. Platteau, K. Zikopoulos, 2004, Human Reproduction.

Intracytoplasmic sperm injection versus in vitro fertilization: a randomized controlled trial and a meta-analysis of the literature.

H. Tournaye, P. Devroey, A. V. Van Steirteghem, 2002, Fertility and sterility.

Four years of IVF/ICSI experience in Kampala (Uganda)

P. Devroey, P. Platteau, B. Desmet, 2008 .

Reproductive outcome of polycystic ovarian syndrome patients treated with GnRH antagonists and recombinant FSH for IVF/ICSI.

H. Tournaye, E. Kolibianakis, P. Devroey, 2003, Reproductive biomedicine online.

Relationship between LH and oestradiol in IVF cycles before GnRH antagonist initiation.

H. Tournaye, E. Kolibianakis, P. Devroey, 2003, Reproductive biomedicine online.